Cambivac Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $97K
Latest Deal Amount
  • Investors
  • 4

Cambivac General Information

Description

Developer of anti-viral drugs intended to be used for the treatment of respiratory diseases in pigs and poultry. The company's drugs are based on antibacterial therapeutics, using synthetic biology to redesign microorganisms that incorporate novel antibacterial features, enabling researchers to produce cheaper vaccines that are more stable, match circulating strains, and have better regional coverage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Unit 1, Cambridge House Camboro Business Park
  • Oakington Road, Girton, Cambridgeshire
  • Cambridge CB3 0QH
  • England, United Kingdom
+44 01223 000000

Cambivac Timeline

2019202020212022
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cambivac Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Jun-2020 $97K Completed Generating Revenue
4. Grant 01-Nov-2019 00000 Completed Generating Revenue
3. Grant 24-Nov-2014 000.00 Completed Startup
2. Early Stage VC Completed Startup
1. Accelerator/Incubator Completed Startup
To view Cambivac’s complete valuation and funding history, request access »

Cambivac Board Members (7)

Name Representing Role Since
Albert Mockett Ph.D Self Board Member 000 0000
Grant Austin Self Board Member 000 0000
Sacha Jean Ignace Seneque Cambivac Board Member 000 0000
Thomas Brown Cambivac Board Member 000 0000
Zoltan Penzes Cambivac Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Cambivac Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cambivac Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
UK Research and Innovation Government 000 0000 000000 0
Babraham Bioscience Technologies Accelerator/Incubator Minority 000 0000 000000 0
Cambridge Enterprise Angel Group Minority 000 0000 000000 0
To view Cambivac’s complete investors history, request access »